ghk cu peptide troche GHK-Cu Copper 89030-95-5 GHK-Cu Gly-His-Lys-Cu Copper Tripeptide-1;

Yes, though with awareness

BPC-157 has shown a favorable safety profile in animal models, with no significant toxicity observed at therapeutic doses

Well-structured treatments lasting 6-12 months with appropriate concentrations typically maintain noticeable improvements over pre-treatment baseline including reduced fine lines (though not eliminated as during peak treatment), improved skin texture and firmness (though less dramatic than treatment peak), better overall skin quality and appearance (though aging continues at normal rates), and resolved specific issues like scarring or hyperpigmentation (which typically remain improved permanently if successfully treated)

DISCLAIMER: These products are intended solely as a research chemical only

But the better framework is matching route to goal